Clinical Trials Directory

Trials / Completed

CompletedNCT02304900

Effect of the Color of the Intra-eye Implant in the Cataract Surgery on the Sleep

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
400 (actual)
Sponsor
University Hospital, Tours · Academic / Other
Sex
All
Age
60 Years – 90 Years
Healthy volunteers
Not accepted

Summary

The cataract surgery (550 000 operations per year in France) is to replace the cloudy lens with a refractive implant. Two colors of implants are available: white implants, filtering out ultraviolet and yellow implants, filtering and more blue light. No clinical data are available to assert the superiority of an implant according to its color and the choice is made according to the preference of the surgeon and / or "markets". It is established in humans that blue light has an important role on the secretion of melanopsin, a key mediator of the circadian cycle. This "clock" regulates most neuroendocrine functions in the nycthémère (sleep, mood, temperature, cortisol, ..). The question of the impact of these neuro endocrine functions of the installation of a blue light filter into the eyes of patients operated thus arises.

Conditions

Interventions

TypeNameDescription
OTHERwhite implant1. st intervention (in the month following the inclusion): Randomization of the color of the implant 2. nd operation (1 to 3 months after the first surgery): Installation of a same color as the first implant operated eye
OTHERyellow implant1. st intervention (in the month following the inclusion): Randomization of the color of the implant 2. nd operation (1 to 3 months after the first surgery): Installation of a same color as the first implant operated eye

Timeline

Start date
2009-12-01
Primary completion
2011-12-01
Completion
2012-12-01
First posted
2014-12-02
Last updated
2025-12-22

Locations

3 sites across 1 country: France

Source: ClinicalTrials.gov record NCT02304900. Inclusion in this directory is not an endorsement.